🟢 Trulieve Cannabis is trading 4.2% up with no clear company-specific catalyst identified

Trulieve Cannabis is trading at $11.24, up 4.17%, with no clear company-specific catalyst identified.

• The DEA proceeding remains stayed as the agency responds to a motion on whether to reopen the rescheduling hearing; reporting does not establish that the procedural deadline drove the gain.
• The broader market is mixed, and supplied index context does not clearly explain the rise.
• The previous session closed up 4.96% at $10.79; today’s gain is based on supplied live-price context.